Balestrino, Roberta
Hurtado-Gonzalez, Carlos Alberto
Stocchi, Fabrizio
Radicati, Fabiana Giada
Chaudhuri, K. Ray
Rodriguez-Blazquez, Carmen http://orcid.org/0000-0003-3829-0675
Martinez-Martin, Pablo http://orcid.org/0000-0003-0837-5280
Adarmes, Astrid D.
Méndez-del-Barrio, Carlota
Ariadne, Vakirli
Aschermann, Zsuzsanna
Juhász, Annamária
Harmat, Márk
Bostantjopoulou, Sevasti
Corbo, Massimo
Grassi, Andrea
Dellaporta, Dionysia
Falup-Pecurariu, Cristian
Diaconu, Ştefania
Giagkou, Nikolaos
Guekht, Alla
Popov, Georgy
Gurevich, Tanya
Johansson, Anders
Sundgren, Mathias
Kefalopoulou, Zinovia
Ellul, John
Kostić, Vladimir S.
Kovacs, Norbert
Marti, Maria J.
Planelles, Lluis
Migirov-Sanderovich, Angel
Ezra, Adi
Minar, Michal
Mir, Pablo
Jan Necpal,
Popovici, Maria
Simitsi, Athima
Stefanis, Leonidas
Simu, Mihaela
Rosca, Cecilia
Skorvanek, Matej
Stefani, Alessandro
Cerroni, Rocco
Stamelou, Maria
Tsolaki, Magda
Vuletic, Vladimira
Katsarou, Zoe
,
Article History
Received: 12 May 2019
Accepted: 18 October 2019
First Online: 27 November 2019
Competing interests
: R.B., C.A.H.G., F.S., C.R.B.: no competing interests as defined by Nature Research, or other interests that might be perceived to influence the interpretation of the article. F.G.R.: received a grant from the European Parkinson’s Disease Association for supporting her role as Coordinator in this study. K.R.C.: Advisory board: AbbVie, UCB, Sunovion, Pfizer, Jazz Pharma, GKC, Bial, Cynapsus, Novartis, Lobsor, Stada, Medtronic, Zambon, Profile, Sunovion. Honoraria for lectures: AbbVie, Britannia, UCB, Mundipharma, Zambon, Novartis, Boeringer Ingelheim Neuroderm, Sunovion, Grants (Investigator Initiated): Britania Pharmaceuticals, AbbVie, UCB, GKC, Bial, Aacdemic grants: EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), Kirby Laing Foundation, NPF, MRC. P.M.M.: Honoraria: from National School of Public Health (ISCIII) and Editorial Viguera for lecturing in courses; International Parkinson and Movement Disorder Society for management of the Program on Rating Scales; Abbvie, Zambon, and HM Hospitales de Madrid for advice in clinical-epidemiological studies. License fee payments for the King’s Parkinson’s Disease Pain scale.